<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7100368\results\search\funders\results.xml">
  <result pre="Research Unit, CAS Key Laboratory of Molecular Virology and Immunology," exact="Institut Pasteur" post="of Shanghai, Chinese Academy of SciencesShanghaiChina[], 2Tsinghua-Peking Center for"/>
  <result pre="Shanghai, Chinese Academy of SciencesShanghaiChina[], 2Tsinghua-Peking Center for Life Sciences," exact="School of Medicine," post="Tsinghua UniversityBeijingChina[], 3Institut Pasteur of Shanghai, Chinese Academy of"/>
  <result pre="Sciences, School of Medicine, Tsinghua UniversityBeijingChina[], 3Institut Pasteur of Shanghai," exact="Chinese Academy of Sciences," post="University of Chinese Academy of SciencesShanghaiChina[], 4Shanghai Public Health"/>
  <result pre="Public Health Clinical Center, Fudan UniversityShanghaiChina Edited by: Lu Lu," exact="Fudan University," post="China Reviewed by: Cheng-Feng Qin, Beijing Institute of Microbiology"/>
  <result pre="Svetlana Khaiboullina, University of Nevada, Reno, United States; Jing An," exact="Capital Medical University," post="China *Correspondence: Xia Jin, xjin@ips.ac.cn; jinxia@shphc.org.cn This article was"/>
  <result pre="immunity vaccine mosquitoes Funding National Natural Science Foundation of China10.13039/501100001809" exact="Ministry of Science and Technology" post="of the People’s Republic of China10.13039/501100002855 Science and Technology"/>
  <result pre="reported in different outbreaks after World War II (Halstead, 1966;" exact="World Health Organization" post="[WHO], 1966). Now, the four serotype viruses are co-circulating"/>
  <result pre="vaccine Dengvaxia (called CYD-TDV before licensure) has been developed by" exact="Sanofi" post="Pasteur. It is a live attenuated vaccine comprised of"/>
  <result pre="adults have died from lethal dengue diseases. By the time" exact="Sanofi" post="Pasteur and WHO modified the instruction for Dengvaxia vaccination"/>
  <result pre="A DNA vaccine under clinical development is developed by US" exact="Naval Medical Research Center," post="and it contains prM and E genes. Monovalent DENV-1"/>
  <result pre="through an endogenous antigen presentation pathway (Cresswell et al., 2005;" exact="Roche" post="and Furuta, 2015; Sadegh-Nasseri and Kim, 2019). Therefore, CD4"/>
  <result pre="of review. Funding. This work was supported by the grant:" exact="National Natural Science Foundation of China," post="31670941; Ministry of Science and Technology of People’s Republic"/>
  <result pre="by the grant: National Natural Science Foundation of China, 31670941;" exact="Ministry of Science and Technology" post="of People’s Republic of China, 2016YFC1201000; Strategic Priority Research"/>
  <result pre="Republic of China, 2016YFC1201000; Strategic Priority Research Program of the" exact="Chinese Academy of Sciences," post="XDB29040000; and Science and Technology Commission of Shanghai Municipality,"/>
  <result pre="Research Program of the Chinese Academy of Sciences, XDB29040000; and" exact="Science and Technology Commission of Shanghai Municipality," post="19ZR1462900. References References AbbinkP.LaroccaR. A.DejnirattisaiW.PetersonR.NkololaJ. P.BorducchiE. N.et al. (2018)."/>
  <result pre="attachment to endosomal membrane induced by prm antibody.Structure27253.e8–267.e8. 10.1016/j.str.2018.10.00930471923 collab:" exact="World Health Organization" post="[WHO] (1966). Mosquito-borne hemorrhagic fevers of South-East Asia and"/>
  <result pre="South-East Asia and the Western Pacific.Bull World Health Organ.3517–33.4381234 collab:" exact="World Health Organization" post="[WHO] (2009). Dengue: Guidelines for Diagnosis, Treatment, Prevention and"/>
  <result pre="for Diagnosis, Treatment, Prevention and Control: New Edition.Geneva: WHO. collab:" exact="World Health Organization" post="[WHO] (2017). Dengue vaccine: WHO position paper, July 2016"/>
 </snippets>
</snippetsTree>
